Cite
HARVARD Citation
Delahousse, J. et al. (2018). Circulating oncometabolite D-2-hydroxyglutarate enantiomer is a surrogate marker of isocitrate dehydrogenase–mutated intrahepatic cholangiocarcinomas. European journal of cancer. pp. 83-91. [Online].